|
Volumn 35, Issue 12, 2001, Pages 1593-1598
|
Verteporfin for age-related macular degeneration
|
Author keywords
Age related macular degeneration; Verteporfin
|
Indexed keywords
BENZOPORPHYRIN DERIVATIVE;
PHOTOSENSITIZING AGENT;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG COST;
DRUG EFFICACY;
DRUG INDICATION;
DRUG LABELING;
DRUG MECHANISM;
HUMAN;
MULTICENTER STUDY;
NONHUMAN;
PATIENT COUNSELING;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PHOTODYNAMIC THERAPY;
PRIORITY JOURNAL;
RETINA MACULA AGE RELATED DEGENERATION;
SIDE EFFECT;
VISUAL DISORDER;
CLINICAL TRIALS;
HUMANS;
MACULAR DEGENERATION;
PHOTOSENSITIZING AGENTS;
PORPHYRINS;
TREATMENT OUTCOME;
|
EID: 0035668365
PISSN: 10600280
EISSN: None
Source Type: Journal
DOI: 10.1345/aph.10365 Document Type: Review |
Times cited : (36)
|
References (15)
|